REFERENCIAS

• Ambrogetti, A., L.G. Olson, and N.A. Saunders. 1991. Differences in the symptoms of men and women with obstruc-tive sleep apnoea. Aust NZ J Med 21: 863-66.
• American Medical Association. 1995. Principles of practice para-meters. Chicago: American Medical Association.
• American Psychiatric Association. 1994. Diagnostic and statistical manual of mental disorders. 4th ed.
• Washington, DC: American Psychiatric Association.
• Archibald, C.J., P.J. McGrath, and P.G. Ritvo et al. 1994. Pain prevalence, severity, and impact in a clinic sample of multiple sclerosis patients. Pain 58: 89-93.
• Bates, D.W., W. Schmitt, and D. Buchwald et al. 1993. Prevalence of fatigue and chronic fatigue in a primary care practice. Arch Intern Med 153: 2759-65.
• Beck, A.T., C.H. Ward, and M. Medelson et al. 1961. An inventory for measuring depression. Arch Gen Psych 4: 561-71.
• Beck, R.W., P.A. Cleary, and J.D. Trobe et al. 1993. The effect of corticosteroids for acute optic neuritis on the subsequent development of multiple sclerosis. N Engl J Med 329: 1764-69.
• Belza, B.L., C.J. Henke, and E.H. Yelin et al. 1993. Correlates of fatigue in older adults with rheumatoid arthritis. Nurs Res 42: 93-99.
• Bever, C.T. 1994. The current status of studies of aminopyridines in multiple sclerosis. Ann Neurol 36 (supplement 1): S118-21. [Review]
• Buchwald, D., J.L. Sullivan, and A.L. Komaroff. 1987. Frequency of chronic active Epstein-Barr virus infection in a general medical practice. JAMA 257: 2303-7.
• Canadian MS Research Group. 1987. A randomized controlled trial of amantadine in fatigue associated with MS. Canadian Journal of Neurosciences 14: 273-78.
• Capello, E., M. Gardella, and M. Leandri et al. 1995. Lowering body temperature with a cooling suit as symptomatic treat-ment of thermosensitive multiple sclerosis patients. Italian Journal of Neurol Sci 16: 533-39.
• Clark, C.M., J.A. Fleming, and D. Li et al. 1992. Sleep disturbance, depression, and lesion site in patients with multiple sclerosis. Arch Neurol 49: 641-43.
• Cohen, R.A., and M. Fisher. 1989. Amantadine treatment of fatigue associated with MS. Archives of Neurology 46: 676-80.
• Cookfair, D., J. Fischer, R.A. Rudick, and the MSCRG. 1997. Fatigue severity in low disability MS patients participating in a phase III trial of Avonex (INF-1a) for relapsing multiple sclerosis. Neurology 48 (supplement 2): A173. [Abstract]
• Copperman, L., and S. Forwell. 1997. MS daily activity diary. Unpublished.
• Copperman, L., C. Hartley, and P. Scharf et al. 1994. Fatigue and mobility. J Neurol Rehabil 8: 131-36.
• Coyle, P.K., L.B. Krupp, and C. Doscher et al. 1996. Clinical and immunological effects of cooling in multiple sclerosis. J Neurol Rehabil 10: 9-14.
• Crawford J.D., and G.P. McIvor. 1987. Stress management for multiple sclerosis patients. Psychological Report s 61: 423-29.
• Davis, F.A., and S. Jacobson. 1971. Altered thermal sensitivity of injured and demyelinated nerve. J Neurol, Neurosurgery, Psychiatry: 34: 551-61.
• Edgley, K., M. Sullivan, and E. Dehoux. 1991. A survey of multiple sclerosis: II Determinants of employment status. Can J Rehabil 4: 127-32.
• Enoka, R.M., and D. Stuart. 1992. Neurobiology of muscle fatigue. J Appl Physiol 72: 1631-48.
• Ferini-Strambi, L., M. Filippi, and V. Martinelli et al. 1994. Nocturnal sleep study in multiple sclerosis: correlations with clinical and brain magnetic resonance image findings. J Neurol Sci 125: 194-97.
• Fisk, J.D., A. Pontefract, and P.G. Ritvo et al. 1994. The impact of fatigue on patients with MS. Can J Neurol Sci 21: 9-14.
• Foglio, K., E. Clini, and D. Facchetti. 1994. Respiratory muscle function and exercise capacity in MS. European Resp Journal 7: 23-28.
• Freal, J.F., G.H. Kraft, and J.K. Coryell. 1984. Symptomatic fatigue in MS. Arch Phys Med Rehabil 65: 135-38.
• Guilleminault, C., R. Stoohs, and Y.-D. Kim. 1995. Upper airway sleep-disordered breathing in women. Ann Intern Med 122: 493-501.
• Jackson, M.F., C. Quaal, and M.A. Reeves. 1991. Effects of multiple sclerosis on occupational and career plans. Axon (Sept): 16-22.
• Joffe, R.T., G.P. Lippert, and T.A. Gray et al. 1987. Mood disorder and multiple sclerosis. Arch Neurol 44: 376-78.
• Johns, M.W. 1991. A new method for measuring daytime sleepi-ness: the Epworth sleepiness scale. Sleep 14: 540-45.
• Kent-Braun, J., K.R. Sharma, and M.W. Weiner et al. 1994. Effects of exercise on muscle activation and metabolism in MS. Muscle & Nerve 17: 1162-69.
• Kroenke, K., D.R. Wood, and A.D. Mangelsdorff et al. 1988. Chronic fatigue in primary care. JAMA 260: 929-34.
• Krupp, L.B., L.A. Alvarez, and N.G. LaRocca et al. 1988. Fatigue in multiple sclerosis. Arch Neurol 45: 435-37.
• Krupp, L.B., P.K. Coyle, and C. Doscher et al. 1995. Fatigue therapy in MS: results of a double-blind, randomized, parallel trial of amantadine, pemoline, and placebo. Neurology 45: 1956-61.
• Krupp, L.B., N.G. LaRocca, and J. Muir-Nash et al. 1989. The fatigue severity scale: application to patients with multiple sclerosis and systemic lupus erythematosus. Archives of Neurology 46: 1121-23.
• Leo, G.J., S.M. Rao, and L. Bernardin. 1991. Sleep disturbances in multiple sclerosis. Neurology 41 (supplement 1): 320. [Abstract]
• Maguire, B.L. 1996. The effects of imagery on attitudes and moods in multiple sclerosis patients. Alternative Therapies in Health and Medicine 2: 75-79.
• Middleton, G.D., J.E. McFarlin, and T.E. Lipsky. 1994. The prevalence and clinical impact of fibromyalgia in systemic lupus erythematosus. Arthritis Rheum 37: 1181-88.
• Miller, R.G., A.T. Green, and R.S. Moussavi et al. 1990. Excessive muscular fatigue in patients with spastic paraparesis. Neurology 40: 1271-74.
• Minden, S.L., J. Orav, and P. Reich. 1987. Depression in multiple sclerosis. General Hospital Psychiatr y 9: 426-34.
• Mohr, D.C., D.E. Goodkin, and W. Likosky et al. 1996. Therapeutic expectations of patients with multiple
• sclerosis upon initiating interferon beta-1b: relationship of adherence to treatment. Multiple Sclerosis 2: 222-26.
• Mohr, D.C., D.E. Goodkin, and W. Likosky et al. 1997. Identification of Beck Depression Inventory items related to multiple sclerosis. J Behavior Med 20 (4):405-12.
• Monks, J. 1989. Experiencing symptoms in chronic illness: fatigue in multiple sclerosis. Int Disabil Stud 11: 78-83.
• Morissey, S.P., D.H. Miller, and B.E. Kendall et al. 1993. The significance of brain magnetic resonance imaging abnor-malities at presentation with clinically isolated syndromes suggestive of multiple sclerosis. Brain 116: 135-46.
• Moulin, D.E., K.M. Foley, and G.C. Ebers. 1988. Pain syndromes in multiple sclerosis. Neurology 38: 1830-34. Murray, T.J. 1985. Amantadine therapy for fatigue in MS. Can J Neurol Sci 12: 251-54.
• Olgiati, R., J.M. Burgunder, and M. Mumenthaler. 1988. Increased energy cost of walking in multiple sclerosis: effect of spasticity, ataxia, and weakness. Archives
• Phys Med & Rehabil 69: 846-49.
• Petajan, J.H., E. Gappmaier, and A.T. White et al. 1996. Impact of aerobic training on fitness and quality of life in multiple sclerosis. Ann Neurology 39: 432-41.
• Rasminsky, M. 1973. The effects of temperature on conduction in demyelinated single nerve fibers. Arch Neurology 28: 287-92.
• Rice, C.L., T.L. Volmer, and B. Bigland-Ritchie. 1992. Neuromuscular responses of patients with multiple sclerosis. Muscle & Nerve 15: 1123-32.
• Ritvo, P.G., J.D. Fisk, and C.J. Archibald et al. 1996. Psychosocial and neurologic predictors of mental health in multiple sclerosis. Journal of Clinical Epidemiology 49: 467-72.
• Roelcke, U., L. Kappos, and J. Lechner-Scott et al. 1997. Reduced glucose metabolism in the frontal cortex and basal ganglion of multiple sclerosis patients with fatigue: an 18F-fluorodeoxyglucose position emission tomography study. Neurology 48: 1566-71.
• Sandroni, P., W. Cameron, and A. Starr. 1992. Fatigue in patients with multiple sclerosis: motor pathway conduction and event-related potentials. A rch Neurol 49: 517-24.
• Saunders, J., R. Whitham, and B. Schaumann. 1991. Sleep disturbance, fatigue, and depression in multiple sclerosi s . Neurology 41 (supplement 1): 320. [Abstract]
• Schapiro, R.T., L. Harris, and M. Lenling et al. "Fatigue," In Schapiro, R.T., editor. 1987. Symptom management in multiple sclerosis. New York: Demos Publications.
• Schiffer, R.B., E.D. Caine, and K.A. Bamford et al. 1983. Depressive episodes in patients with multiple sclerosis. Amer J Psych 140: 861-65.
• Schwartz, C.E., L. Coulthard-Morris, and Q. Zeng. 1996. Psychosocial correlates of fatigue in multiple sclerosis. Arch Phys Med & Rehabil 77: 165-70.
• Schwartz, J.E., L. Jandorf, and L.B. Krupp. 1993. The measurement of fatigue: a new instrument. J of Psychosomatic Research 37: 753-62.
• Shapiro, R.T., J.H. Petajan, and D. Kosich et al. 1988. Role of cardiovascular fitness in MS: a pilot study. J Neurol Rehabil 2: 43-49.
• Sharma, K.R., J. Kent-Braun, and M.A. Mynhier et al. 1995. Evidence of an abnormal intramuscular component of fatigue in MS. Muscle & Nerve 18: 1403-11.
• Sheean, G.L., N.M.F. Murray, and J.C. Rotwell et al. 1997. An electrophysiological study of the mechanism of fatigue in multiple sclerosis. Brain 120: 299-315.
• Smeltzer, S.C., M.H. Lavietes, and S.D. Cook. 1996. Expiratory training in multiple sclerosis. Arch Phys Med & Rehabil 77: 909-12.
• Syndulko, K., M. Jafari, and A. Woldanski et al. 1996. Effects of temperature in multiple sclerosis: a review of the literature. J Neuro Rehab 10: 23-34.
• Vercoulen, J.H.M.M., O.R. Hommes, and C.M.A. Swanink et al. 1996a. The measurement of fatigue in patients with MS. Arch Neurol 53: 642-49.
• Vercoulen, J.H.M.M., C.M.A. Swanink, and J.M.D. Galama et al. 1994. Dimensional assessment in chronic fatigue syndrome. J Psychosomatic Research 38: 383-92.
• Vercoulen, J.H.M.M., C.M.A. Swanink, and F.G. Zitman et al. 1996b. Randomized, double-blind, placebo-controlled study of fluoxetine in chronic fatigue syndrome. Lancet 347: 858-61.
• Warnell, P. 1991. The pain experience of a multiple sclerosis population: a descriptive study. Axon 13: 26-28.
• Weinshenker, B.G., M. Penman, and B. Bass et al. 1992. A double-blind, randomized, crossover trial of pemoline in fatigue associated with multiple sclerosis. Neurology 42: 1468-71.
• Welham, L. 1995. Occupational therapy for fatigue in patients with multiple sclerosis. British J. Occupational Therapy 58: 507-9.
• Whitlock, F.A., and M.M. Siskind. 1980. Depression as a major symptom of multiple sclerosis. Journal of Neurol Neurosurg Psych 43: 861-65.
• Woolf, S.H. 1992. Practice guidelines, a new reality in medicine: II. Methods of developing guidelines. Archives of Internal Medicine 52: 946-52.